GlassScriptPhysician profile
Shazia Mitha
NPI 1669921813
$3,116.57
in general payments reported to CMS, 2019-2025
17 companies · $2,503 in 2025
The $2,503 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.25 · 2022: $431 · 2023: $160 · 2025: $2,503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,853 · Travel and Lodging: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,853.43 |
| Travel and Lodging | $810.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,230.95 | 2025 | Indigo System |
| Jazz Pharmaceuticals INC. | $381.46 | 2025 | |
| Janssen Biotech, INC. | $241.30 | 2025 | Rybrevant, Carvykti |
| Amgen INC. | $169.99 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $142.66 | 2022-2023 | |
| Janssen Scientific Affairs, LLC | $137.50 | 2025 | Tecvayli, Talvey, Darzalex |
| Galvanize Therapeutics, INC | $127.46 | 2025 | Aliya System |
| Lilly USA, LLC | $121.84 | 2025 | Jaypirca |
| Ipsen Biopharmaceuticals, INC | $121.57 | 2025 | Onivyde |
| Foundation Medicine, INC. | $98.71 | 2022 | |
| Karyopharm Therapeutics INC. | $95.63 | 2023 | Xpovio |
| Pharmacyclics LLC, An Abbvie Company | $83.86 | 2022 | |
| Novartis Pharmaceuticals Corporation | $61.20 | 2025 | |
| Daiichi Sankyo INC. | $29.76 | 2025 | Enhertu |
| Geron Corporation | $25.85 | 2025 | Rytelo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fennec Pharmaceuticals, INC. | $24.58 | 2025 | Fyarro |
| Janssen Pharmaceuticals, INC | $22.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shazia Mitha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.